United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 1 minute read Healthcare Industry News Morepen Laboratories spins out medical devices business Morepen Laboratories Limited said that it has separated its point of care (POC) medical devices business into a… byPallavi MadhirajuOctober 6, 2021